Focal epilepsy

Related records

Broader conditions (7)

• Brain disorder
• Central nervous system disorder
• Disease
• Disease by body system or component
• Epilepsy
• Human disease
• Nervous system disorder

Narrower conditions (44)

• Acquired sleep-related hypermotor epilepsy
• Autosomal dominant epilepsy with auditory features
• Autosomal dominant nocturnal frontal lobe epilepsy 1
• Autosomal dominant nocturnal frontal lobe epilepsy 2
• Autosomal dominant nocturnal frontal lobe epilepsy 3
• Autosomal dominant nocturnal frontal lobe epilepsy 4
• Autosomal dominant nocturnal frontal lobe epilepsy 5
• Childhood occipital visual epilepsy
• Childhood-onset self-limited focal epilepsy syndrome
• Combined generalized and focal epilepsy
• Complex partial epilepsy
• Epilepsy with auditory features
• Epilepsy, familial focal, with variable foci 1
• Epilepsy, familial focal, with variable foci 2
• Epilepsy, familial focal, with variable foci 3
• Epilepsy, familial focal, with variable foci 4
• Epilepsy, familial temporal lobe, 1
• Familial focal epilepsy with variable foci
• Familial mesial temporal lobe epilepsy
• Familial partial epilepsy

Trials (266)

• A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
• A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
• A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures
• A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
• A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
• A New Method for Delineation of Epileptic Brian Tissue During Epilepsy Surgery (The HFO Study)
• A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
• A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures
• A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures
• A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy
• A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.
• A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)
• A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)
• A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
• A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures
• A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.
• A Study of Brivaracetam in Subjects With Partial Onset Seizures
• A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy

Approved drugs (6)

• Carbamazepine
• Lacosamide
• Lamotrigine
• Perampanel
• Vigabatrin
• Zonisamide

Drugs in development (20)

• Azetukalner Phase 2
• Belnacasan Phase 2
• Brivaracetam Phase 3
• Carisbamate Phase 3
• Cenobamate Phase 3
• Diazepam Phase 3
• Eslicarbazepine acetate Phase 3
• Gabapentin Phase 3
• Ganaxolone Phase 2
• Ibuprofen Phase 2
• Levetiracetam Phase 3
• Natalizumab Phase 2
• Nifedipine Phase 2
• Oxcarbazepine Phase 3
• Padsevonil Phase 2
• Pregabalin Phase 3
• Probenecid Phase 2
• Seletracetam Phase 2
• Topiramate Phase 3
• Valproic acid Phase 1

Other linked drugs (2)

• Ezogabine
• Fluoxetine